CD93 and cancer: Compared with naïve mice, the total number of CD93+ BMBP was markedly decreased in BM but increased in the spleen as well as present in the tumors of mice with 4T1.2 and Mogp cancers (Fig. 5a, Supplementary Fig. 7a, b and not depicted).